Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3093

Actual shortage: 246 (8%)
Anticipated shortage: 15 (0%)
Avoided shortage: 9 (0%)
Resolved: 2823 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-01-30 2020-11-03 74033
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-02-21 2019-04-05 76582
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-02-24 2019-04-15 76726
APO-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2019-02-24 2020-11-03 76735
APO-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2019-02-24 2020-11-03 76740
APO-DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2019-04-10 2019-05-14 80926
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-04-24 2019-06-21 82337
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-04-30 2019-05-13 82837
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-05-08 2019-06-24 83504
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-05-15 2019-06-24 84159
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-06-05 2019-06-21 85619
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-07-03 2019-08-03 88336
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-08-21 2019-09-16 92019
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-08-21 2019-08-30 92026
APO-DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2019-09-25 2019-11-04 94734
APO-CLARITHROMYCIN XL 500MG TABLET (EXTENDED-RELEASE) Resolved 2019-10-02 2021-07-15 95266
APO-FELODIPINE 2.5MG TABLET (EXTENDED-RELEASE) Resolved 2019-10-16 2019-11-18 96647
APO-OXYCODONE CR 40MG TABLET (EXTENDED-RELEASE) Resolved 2019-11-27 2020-03-02 99792
APO-METFORMIN ER 1000MG TABLET (EXTENDED-RELEASE) Resolved 2019-12-05 2021-05-03 100281
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Resolved 2019-12-05 2023-07-04 100284

Showing 2881 to 2900 of 3093

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71032
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71035
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71038
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71044
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71048
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71051
APO-VALSARTAN/HCTZ Discontinued 2019-01-03 2019-01-03 71057
ACID CONTROL Discontinued 2019-01-04 2019-01-04 71198
APO-RIZATRIPTAN RPD Discontinued 2019-01-04 2019-04-04 71334
APO PEN VK Discontinued 2019-03-08 2019-03-08 78141
APO PEN VK Discontinued 2019-03-08 2019-03-08 78144
APO-ALMOTRIPTAN Discontinued 2019-05-13 2019-05-13 83971
APO-ALMOTRIPTAN Discontinued 2019-05-13 2019-05-13 83976
APO-AMOXI CLAV 250MG/62.5MG PER 5ML Discontinued 2019-05-13 2019-05-13 83981
APO-AMOXI CLAV Discontinued 2019-05-17 2019-05-18 84392
APO-CEFPROZIL Discontinued 2019-05-17 2019-05-18 84396
APO-CEFPROZIL Discontinued 2019-06-12 2019-06-12 86542
APO-CIPROFLOX Discontinued 2019-06-12 2019-06-12 86547
APO-EXEMESTANE Discontinued 2019-06-12 2019-06-12 86552
APO-GEMFIBROZIL CAP 300MG USP Discontinued 2019-06-12 2019-06-12 86557

Showing 21 to 40 of 356